1. Immune Resolution Dilemma: Host Antimicrobial Factor S100A8/A9 Modulates Inflammatory Collateral Tissue Damage During Disseminated Fungal Peritonitis
- Author
-
Madhu Shankar, Nathalie Uwamahoro, Emelie Backman, Sandra Holmberg, Maria Joanna Niemiec, Johannes Roth, Thomas Vogl, and Constantin F. Urban
- Subjects
lcsh:Immunologic diseases. Allergy ,0301 basic medicine ,Immunology ,Colony Count, Microbial ,Peritonitis ,Inflammation ,S100A8/A9 complex ,S100A9 ,S100A8 ,Immunomodulation ,sepsis ,Sepsis ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,Candida albicans ,medicine ,Animals ,Calgranulin B ,host-pathogen interactions ,Immunology and Allergy ,Calgranulin A ,peritonitis ,Disease Resistance ,Original Research ,business.industry ,Septic shock ,Macrophages ,Immunology in the medical area ,host-targeted agents ,Prognosis ,medicine.disease ,Disease Models, Animal ,030104 developmental biology ,Mycoses ,inflammation ,Immunologi inom det medicinska området ,Cytokines ,Disease Susceptibility ,Inflammation Mediators ,medicine.symptom ,Calprotectin ,lcsh:RC581-607 ,business ,Biomarkers ,030217 neurology & neurosurgery - Abstract
Intra-abdominal infection (peritonitis) is a leading cause of severe disease in surgical intensive care units, as over 70% of patients diagnosed with peritonitis develop septic shock. A critical role of the immune system is to return to homeostasis after combating infection. S100A8/A9 (calprotectin) is an antimicrobial and pro-inflammatory protein complex used as a biomarker for diagnosis of numerous inflammatory disorders. Here we describe the role of S100A8/A9 in inflammatory collateral tissue damage (ICTD). Using a mouse model of disseminated intra-abdominal candidiasis (IAC) in wild-type and S100A8/A9-deficient mice in the presence or absence of S100A9 inhibitor paquinimod, the role of S100A8/A9 during ICTD and fungal clearance were investigated. S100A8/A9-deficient mice developed less ICTD than wild-type mice. Restoration of S100A8/A9 in knockout mice by injection of recombinant protein resulted in increased ICTD and fungal clearance comparable to wild-type levels. Treatment with paquinimod abolished ICTD and S100A9-deficient mice showed increased survival compared to wild-type littermates. The data indicates that S100A8/A9 controls ICTD levels and antimicrobial activity during IAC and that targeting of S100A8/A9 could serve as promising adjunct therapy against this challenging disease.
- Published
- 2021
- Full Text
- View/download PDF